Earnings calendar

Halozyme Therapeutics, Inc. (HALO) earnings: date, estimates, results and stock reactions

Next earnings: Q4 FY2026 on 2027-02-16 (expected, time not announced). EPS estimate 2.57, revenue estimate 551.4M.

Over the last 12 reports the stock moved 9.4% on average (either way), rising 9 times and falling 3. EPS beat estimates 10 of 12 times; revenue 6 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-052.392.30+3.9%493.0M491.6M-20.5%
Q2 FY20262026-08-062.281.79+27.4%481.0M402.3M+23.4%
Q1 FY20262026-05-111.601.55+3.2%376.7M358.6M+10.6%
Q4 FY20252026-02-17-0.242.15-111.2%451.8M435.7M-7.8%
Q3 FY20252025-11-031.721.63+5.5%354.3M446.5M+4.4%
Q2 FY20252025-08-051.541.23+25.2%325.7M330.8M+3.9%
Q1 FY20252025-05-061.110.95+16.8%264.9M281.0M+15.7%
Q4 FY20242025-02-181.261.17+7.7%298.0M285.7M-0.9%

HALO stock report · Earnings calendar